Selamectin is the topical antiparasitic behind two of the most-used cat preventives in the United States: Revolution (selamectin alone, FDA-approved in 1999) and Revolution Plus (selamectin plus the isoxazoline sarolaner, approved in November 2018). Millions of doses go onto cats every year, and the overwhelming majority cause nothing more troubling than a temporary stiff patch of fur at the application site. A minority do generate reports — and those reports, read in aggregate, tell a useful story about what selamectin actually does to cats and what warrants a phone call to the clinic.

VetMedGuide analyzed the FDA Center for Veterinary Medicine (CVM) public adverse-event database, a June 2026 extract containing 1.34 million reports. We identified 21,883 reports naming selamectin in cats and tabulated their reactions, outcomes, administration routes, and reporting history. The picture is dominated by one theme: application-site reactions are far and away the most-reported event, followed by a lack-of-efficacy cluster and a smaller but important group of neurologic and gastrointestinal signs. A fatal outcome appears in a small percentage of reports, almost always in the context of a sick or older cat.

How we identified reports

FDA's public database masks brand names, so reports were matched on the active ingredient selamectin. The database records selamectin under two distinct codes: selamectin alone — the active in Revolution and generic-selamectin products — and a separate combination code for selamectin plus sarolaner (Revolution Plus). The 21,883 reports analyzed here are the selamectin-alone reports in cats; Revolution Plus is tracked under its own combination code (an earlier VetMedGuide species-wide analysis counted roughly 7,560 cat reports there), so the isoxazoline neurologic signal specific to the combination product sits partly in that separate bucket and is noted where relevant below. The FDA cautions that spontaneous reports cannot establish causation or true event rates.

The numbers at a glance

The dataset spans 1999 through 2025, which means it captures the entire post-launch history of selamectin in cats — from Revolution's 1999–2001 early-reporting surge (1,293 reports in the year 2000 alone) through Revolution Plus's November 2018 introduction and beyond.

Application-site reactions lead by a wide margin

Add these terms together and application-site reactions account for roughly 11,000 coded events — by far the largest cluster in the entire dataset. This matches the Revolution Plus label's post-approval experience section, which lists application-site reactions (alopecia, lesions, erythema, pruritus) first, in decreasing order of frequency. For owners, this is the expected, usually benign end of the spectrum: a patch of hair thins or falls out where the liquid was applied, the skin may look pink or scaly for a few days, and it resolves without treatment. Applying the product to the skin over the back of the neck — where the cat cannot lick it off — and letting it dry before contact is the single most effective way to minimize even these minor reactions.

Lack-of-efficacy reports: a reminder that preventives can fail

Breakthrough infestations are the second-largest cluster. Some of these reflect genuine product failure, but most reflect the operational realities of topical prevention: a bath or swimming within hours of application, incomplete dosing, missed monthly doses, or reinfestation from the environment between doses. The clinical takeaway is that a cat still scratching fleas a month after a dose is not necessarily experiencing a drug "defect" — the question is whether the dose was applied correctly, on schedule, and to dry skin.

Accidental oral ingestion is a real and avoidable risk

Across the 21,883 reports, 1,346 listed an oral route — meaning the cat ingested some or all of the product. The most common mechanism is the cat turning to groom the application site before it dries. Oral ingestion of a selamectin topical (which contains isopropyl alcohol) commonly produces hypersalivation, vomiting, diarrhea, lethargy, and in some cases tremors. The label instructs owners not to allow ingestion; in practice that means applying high on the back of the neck, separating cats that groom each other, and watching the application site until it is dry. Most oral-exposure cases are mild and self-limiting, but profuse salivation, tremors, or collapse warrant a call to the clinic or a poison control line.

The neurologic signal

Neurologic signs — tremors, ataxia, and rarely seizure — appear in a small fraction of reports. Both the Revolution and Revolution Plus labels note that sarolaner (in Revolution Plus) is an isoxazoline, a class the FDA has flagged as associated with neurologic adverse reactions including tremors, ataxia, and seizures, even in animals without prior neurologic disease. Cats with a history of seizures warrant a specific conversation about whether an isoxazoline-containing product is the right choice; a selamectin-only product (Revolution) avoids that class effect for the flea/heartworm/ear-mite indications, though it does not add tick coverage.

How the death-outcome number should be read

1,086 reports listed "Died" and 174 "Euthanized" — about 5.8% of selamectin-in-cat reports carried a death outcome. As with any spontaneous-reporting database, this is not a mortality rate. Reports skew toward severe outcomes because mild events rarely get reported; sick, elderly, and very young animals are over-represented; and the long time window over which a cat might be on monthly selamectin means coincident illness is common. The label's own post-approval language includes "rare reports of death." Read together, the signal is that fatal outcomes do occur in cats on selamectin and get reported, not that selamectin is a leading cause of feline death. A cat that becomes acutely ill shortly after application — especially with breathing difficulty, collapse, or severe vomiting — should be seen immediately, as that pattern can reflect a hypersensitivity reaction.

What the breed and sex data show

Males (10,505) outnumbered females (8,319), though this is more likely a reporting artifact than a true sex-based risk. The breed distribution simply mirrors the domestic-cat population; no breed emerges as disproportionately affected in this data.

What to ask your veterinarian

Selamectin remains a well-tolerated, broadly useful preventive for the great majority of cats. The questions that make the choice sharper:

• Revolution or Revolution Plus? Revolution (selamectin alone) covers fleas, heartworm, ear mites, and some intestinal worms. Revolution Plus adds sarolaner for tick coverage. If tick exposure is minimal and the cat has any neurologic history, selamectin alone avoids the isoxazoline class.
• How do I avoid ingestion reactions? Apply to the back of the neck on dry skin, separate grooming housemates, and let it dry before contact.
• What if the application site looks sore or hairless? Mild, temporary hair loss and redness are expected and resolve. Persistent sores, scabs, or spreading redness warrant a recheck — and note the application site so a different location is used next time.
• When is a sign an emergency? Breathing difficulty, facial swelling, collapse, tremors, or seizure within hours of application — seek immediate care.

If you suspect a reaction, report it. Ask your veterinarian to file an adverse drug event report with the manufacturer and the FDA; the database analyses like this one depend on that reporting.

Sources

• FDA CVM, animal adverse-event database (public extract, June 2026); analysis by VetMedGuide. The FDA cautions that spontaneous reports do not establish causation or true event rates. https://www.fda.gov/animal-veterinary/safety-health/reporting-animal-drug-and-device-side-effects-and-product-problems
• Revolution Plus (selamectin and sarolaner) prescribing information, DailyMed (post-approval adverse events, isoxazoline neurologic warning). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbcc7b04-f3ab-4f3e-a38f-dcdc313e1b8a
• FDA, isoxazoline flea-and-tick product fact sheet for pet owners and veterinarians (neurologic adverse reactions, including tremors, ataxia, and seizures). https://www.fda.gov/animal-veterinary/animal-health-literacy/fact-sheet-pet-owners-and-veterinarians-about-potential-adverse-events-associated-isoxazoline-flea
• FOI Summary, NADA 141-502, Revolution Plus original approval (November 9, 2018; field-study adverse reactions in cats). https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/5847
• Revolution (selamectin) prescribing information and post-approval adverse reactions (transient application-site alopecia; rare reports of seizures and death). https://www.drugs.com/pro/revolution-topical.html